Accessibility Menu
 
iShares Trust - iShares Genomics Immunology And Healthcare ETF logo

iShares Trust - iShares Genomics Immunology And Healthcare ETF

(NYSEMKT) IDNA

Current Price$29.56
Market CapN/A
Since IPO (2019)+24%
5 Year-36%
1 Year+44%
1 Month+0%

iShares Trust - iShares Genomics Immunology And Healthcare ETF Financials at a Glance

Market Cap

N/A

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.31

Beta (Volatility)

0.00 (Low)

Price

$29.56

Volume

67,699.751

Open

$29.45

Previous Close

$29.65

Daily Range

$29.42 - $29.68

52-Week Range

$19.11 - $31.41

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About iShares Trust - iShares Genomics Immunology And Healthcare ETF

Industry

Capital Markets

Headquarters

New York, NY 10001, US

IDNA Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

$0.00

Shares Outstanding

5.45M

Volume

67.70K

Avg. Volume

0

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

iShares Trust - iShares Genomics Immunology And Healthcare ETF Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

$0.00

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Net Cash

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IMOMAlpha Architect International Quantitative Momentum ETF
$43.94-0.74%
ECOWPacer Emerging Markets Cash Cows 100 ETF
$27.71-0.16%
LEGRFirst Trust Indxx Innovative Transaction & Process ETF
$62.20-0.91%
EMXFiShares ESG Advanced MSCI EM ETF
$53.41-0.12%

Trending Stocks

Symbol / CompanyPricePrice Chg
CNSPCns Pharmaceuticals
$7.84+2.39%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.18+0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.69-0.00%
TQQQProShares Trust - ProShares UltraPro Qqq
$64.91-0.01%

Questions About IDNA

What is the current price of iShares Trust - iShares Genomics Immunology And Healthcare ETF?

iShares Trust - iShares Genomics Immunology And Healthcare ETF is trading at $29.65 per share.

What is the 52-week range for iShares Trust - iShares Genomics Immunology And Healthcare ETF?

Over the past 52 weeks, iShares Trust - iShares Genomics Immunology And Healthcare ETF has traded between $19.11 and $31.41.

How much debt does iShares Trust - iShares Genomics Immunology And Healthcare ETF have?

iShares Trust - iShares Genomics Immunology And Healthcare ETF total debt is unavailable.

How much cash does iShares Trust - iShares Genomics Immunology And Healthcare ETF have on hand?

iShares Trust - iShares Genomics Immunology And Healthcare ETF does not have cash on hand data available.

What is iShares Trust - iShares Genomics Immunology And Healthcare ETF’s dividend yield?

iShares Trust - iShares Genomics Immunology And Healthcare ETF does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.